Patents by Inventor Dennis Benjamin

Dennis Benjamin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951793
    Abstract: A method and apparatus for a vehicle suspension system gas spring. In one embodiment, a vehicle suspension system gas spring includes a compressible main gas chamber and an additional volume combinable with the main chamber to change a gas spring rate of the system. In one embodiment, a low friction piston seal is created by a flexible seal member.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: April 9, 2024
    Assignee: Fox Factory, Inc.
    Inventors: Mario Galasso, Joshua Benjamin Yablon, Andrew Laird, William M. Becker, Joseph Franklin, Dennis K. Wootten
  • Publication number: 20230033859
    Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Application
    Filed: March 8, 2022
    Publication date: February 2, 2023
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Patent number: 11331394
    Abstract: This invention, among other things, relates to CD19 binding agents and methods of using such CD binding agents for treating disease.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: May 17, 2022
    Assignee: SEAGEN INC.
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Publication number: 20210260086
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 26, 2021
    Inventors: Peter SENTER, Stephen ALLEY, Dennis BENJAMIN
  • Patent number: 11033561
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: June 15, 2021
    Assignee: SEAGEN INC.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin
  • Publication number: 20200061091
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Application
    Filed: June 25, 2019
    Publication date: February 27, 2020
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin
  • Patent number: 10342811
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 9, 2019
    Assignee: Seattle Genetics, Inc.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin
  • Patent number: 10155672
    Abstract: A method and apparatus for operating an electro-deionization (EDI) module produces purified water using a power supply controller to provide more efficient and accurate operation.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: December 18, 2018
    Assignee: SARTORIUS LAB INSTRUMENTS GMBH & CO. KG
    Inventors: Matthias Grabosch, Dennis Benjamin Groesche, Fabian Walter, Gaston De Los Reyes
  • Publication number: 20180326087
    Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Application
    Filed: February 14, 2018
    Publication date: November 15, 2018
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Patent number: 9919061
    Abstract: This invention relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: March 20, 2018
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Publication number: 20180000961
    Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Application
    Filed: June 18, 2015
    Publication date: January 4, 2018
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Publication number: 20170298118
    Abstract: The invention provides methods for making antibody conjugates for use in antibody screening assays and antibody conjugates produced by the claimed methods.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 19, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Robert Lyon, Dennis Benjamin, Maureen Ryan
  • Patent number: 9725500
    Abstract: The invention provides methods for making antibody conjugates for use in antibody screening assays and antibody conjugates produced by the claimed methods.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: August 8, 2017
    Assignee: Seattle Genetics, Inc.
    Inventors: Robert Lyon, Dennis Benjamin, Maureen Ryan
  • Publication number: 20170035790
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 9, 2017
    Applicant: Seattle Genetics, Inc.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin
  • Patent number: 9504702
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: November 29, 2016
    Assignee: Seattle Genetics, Inc.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin
  • Publication number: 20150336820
    Abstract: A method and apparatus for operating an electro-deionization (EDI) module produces purified water using a power supply controller to provide more efficient and accurate operation.
    Type: Application
    Filed: January 8, 2014
    Publication date: November 26, 2015
    Inventors: Matthias GRABOSCH, Dennis Benjamin GROESCHE, Fabian WALTHER, Gaston DE LOS REYES
  • Publication number: 20150283255
    Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Application
    Filed: June 18, 2015
    Publication date: October 8, 2015
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Patent number: 9073993
    Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: July 7, 2015
    Assignee: Seattle Genetics, Inc.
    Inventors: Charlotte McDonagh, Charles G. Cerveny, Dennis Benjamin, Paul Carter
  • Patent number: 8598089
    Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: December 3, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffan Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
  • Publication number: 20130129784
    Abstract: The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
    Type: Application
    Filed: August 5, 2011
    Publication date: May 23, 2013
    Applicant: Seattle Genetics, Inc.
    Inventors: Peter Senter, Stephen Alley, Dennis Benjamin